Circular RNAs in tumor immunity and immunotherapy

W Zhang, C Xu, Z Yang, J Zhou, W Peng, X Zhang… - Molecular Cancer, 2024 - Springer
Circular RNAs (circRNAs) are unique noncoding RNAs that have a closed and stable loop
structure generated through backsplicing. Due to their conservation, stability and tissue …

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks

L Meng, H Wu, J Wu, P Ding, J He, M Sang… - Cell Death & Disease, 2024 - nature.com
Current treatment strategies for cancer, especially advanced cancer, are limited and
unsatisfactory. One of the most substantial advances in cancer therapy, in the last decades …

High-dimensional multi-pass flow cytometry via spectrally encoded cellular barcoding

SJJ Kwok, S Forward, MD Fahlberg, ER Assita… - Nature biomedical …, 2024 - nature.com
Advances in immunology, immuno-oncology, drug discovery and vaccine development
demand improvements in the capabilities of flow cytometry to allow it to measure more …

Immune checkpoint inhibitors for the treatment of sepsis: insights from preclinical and clinical development

M Rienzo, T Skirecki, G Monneret… - Expert opinion on …, 2022 - Taylor & Francis
Introduction It is now well established that sepsis induces a state of acquired
immunosuppression, with an increased risk of secondary infections that contributes to …

[HTML][HTML] Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers

Y Gao, X Wang, L Dong, C Qu, Q Lu, P Wang, M Xin… - Scientific Data, 2023 - nature.com
Long non-coding RNAs (lncRNAs) could modulate expression of immune checkpoints
(ICPs) in tumor-immune. However, precise functions in immunity and potential for predicting …

Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer

X Gong, C Zheng, Y Cai, W Zhang, B Zhu… - Journal of Controlled …, 2024 - Elsevier
Adenosine (ADO) is a common chemotherapy-associated immune checkpoint that hinders
anti-tumor immunity-mediated efficacy of chemotherapy. Herein, we created a synthetic high …

The interplay between metabolic adaptations and Diet in Cancer Immunotherapy

L Espelage, N Wagner, JM Placke, S Ugurel… - Clinical Cancer …, 2024 - aacrjournals.org
Over the past decade, cancer immunotherapy has significantly advanced through the
introduction of immune checkpoint inhibitors and the augmentation of adoptive cell transfer …

On demand biosensors for early diagnosis of cancer and immune checkpoints blockade therapy monitoring from liquid biopsy

S Mummareddy, S Pradhan, AK Narasimhan… - Biosensors, 2021 - mdpi.com
Recently, considerable interest has emerged in the development of biosensors to detect
biomarkers and immune checkpoints to identify and measure cancer through liquid biopsies …

A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells

VS Donnenberg, JD Luketich, I Sultan, J Lister… - Frontiers in …, 2023 - frontiersin.org
Introduction Treatment options for patients with malignant pleural effusions (MPE) are limited
due, at least in part, to the unique environment of the pleural space, which drives an …

Immune checkpoint inhibitors in infectious disease

HAD King, SR Lewin - Immunological Reviews, 2024 - Wiley Online Library
Following success in cancer immunotherapy, immune checkpoint blockade is emerging as
an exciting potential treatment for some infectious diseases, specifically two chronic viral …